Related references
Note: Only part of the references are listed.Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation
Taiwo Ngwa et al.
BMC GASTROENTEROLOGY (2020)
Evaluation and Management of Esophageal and Gastric Varices in Patients with Cirrhosis
Sofia Simona Jakab et al.
CLINICS IN LIVER DISEASE (2020)
Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding
Jongbeom Shin et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2020)
Comparison of Therapies for Primary Prevention of Esophageal Variceal Bleeding: A Systematic Review and Network Meta-analysis
Mayank Sharma et al.
HEPATOLOGY (2019)
Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis
Xiangbo Xu et al.
HEPATOLOGY INTERNATIONAL (2019)
Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial
Manoj Kumar et al.
HEPATOLOGY INTERNATIONAL (2019)
Assessing the safety of beta-blocker therapy in cirrhosis patients with ascites: A meta-analysis
Robert J. Wong et al.
LIVER INTERNATIONAL (2019)
The Impact of Cirrhosis and Prescription Medications on QTc Interval Before and After Liver Transplantation
Andrew D. Santeusanio et al.
JOURNAL OF PHARMACY PRACTICE (2019)
Study protocol for a randomised controlled trial of carvedilol versus variceal band ligation in primary prevention of variceal bleeding in liver cirrhosis (CALIBRE trial)
Dhiraj Tripathi et al.
BMJ OPEN GASTROENTEROLOGY (2019)
Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites
Alberto Ferrarese et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2018)
Beta-blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation
A. Q. Bhutta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Portal Hypertensive Bleeding in Cirrhosis: Risk Stratification, Diagnosis, and Management: 2016 Practice Guidance by the American Association for the Study of Liver Diseases
Guadalupe Garcia-Tsao et al.
HEPATOLOGY (2017)
Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites
Rohit Sinha et al.
JOURNAL OF HEPATOLOGY (2017)
Prevention and treatment of variceal haemorrhage in 2017
Felix Brunner et al.
LIVER INTERNATIONAL (2017)
Non-selective beta-blockers are not associated with increased mortality in cirrhotic patients with ascites
Simona Onali et al.
LIVER INTERNATIONAL (2017)
Beta-Blockers in Patients With Advanced Liver Disease: Has the Dust Settled?
Carlos Moctezuma-Velazquez et al.
LIVER TRANSPLANTATION (2017)
Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates
Sang Gyune Kim et al.
LIVER TRANSPLANTATION (2017)
Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices
Bernhard Scheiner et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Ivabradine: Current and Future Treatment of Heart Failure
Lene Thorup et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2017)
QT prolongation is associated with increased mortality in end stage liver disease
Sun Moon Kim et al.
WORLD JOURNAL OF CARDIOLOGY (2017)
A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis
Sang G. Kim et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Nonselective β-Blockers and Survival in Patients With Cirrhosis and Ascites: A Systematic Review and Meta-analysis
Sakkarin Chirapongsathorn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Nonselective β-Blockers Do Not Affect Mortality in Cirrhosis Patients With Ascites: Post Hoc Analysis of Three Randomized Controlled Trials With 1198 Patients
Lars Bossen et al.
HEPATOLOGY (2016)
Beta blockers in cirrhosis: The window re-opens
Guadalupe Garcia-Tsao
JOURNAL OF HEPATOLOGY (2016)
Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure
Rajeshwar P. Mookerjee et al.
JOURNAL OF HEPATOLOGY (2016)
Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study
Vijendra Kirnake et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2016)
Prognosis of Acute Variceal Bleeding: Is Being on Beta-Blockers an Aggravating Factor? A Short-Term Survival Analysis
Andrea Ribeiro de Souza et al.
HEPATOLOGY (2015)
The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis
Thomas Serste et al.
LIVER INTERNATIONAL (2015)
Non-selective beta-blockers may reduce risk of hepatocellular carcinoma: a meta-analysis of randomized trials
Maja Thiele et al.
LIVER INTERNATIONAL (2015)
Non-selective β-blockers are associated with improved survival in patients with ascites listed for liver transplantation
Joanna A. Leithead et al.
GUT (2015)
Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis
E. Sinagra et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis
Mattias Mandorfer et al.
GASTROENTEROLOGY (2014)
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
Agustin Albillos et al.
JOURNAL OF HEPATOLOGY (2014)
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure
Rajiv Jalan et al.
JOURNAL OF HEPATOLOGY (2014)
Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis
Xing-Shun Qi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Targeting the Gut-Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers
Bjorn S. Madsen et al.
ADVANCES IN THERAPY (2013)
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
Richard Moreau et al.
GASTROENTEROLOGY (2013)
Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial
Shiv Kumar Sarin et al.
HEPATOLOGY INTERNATIONAL (2013)
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis
Thomas Reiberger et al.
JOURNAL OF HEPATOLOGY (2013)
All beta-blockers are created equal, but some beta-blockers are more equal than others
Rajeshwar P. Mookerjee et al.
LIVER INTERNATIONAL (2013)
Can non-selective beta-blockers prevent hepatocellular carcinoma in patients with cirrhosis?
Maja Thiele et al.
MEDICAL HYPOTHESES (2013)
Patients Whose First Episode of Bleeding Occurs While Taking a β-Blocker Have High Long-term Risks of Rebleeding and Death
Andrea Ribeiro de Souza et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease
Aleksander Krag et al.
GUT (2012)
The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension
Yeon Seok Seo et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2012)
Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: A cross-over study
Thomas Serste et al.
JOURNAL OF HEPATOLOGY (2011)
Deleterious Effects of Beta-Blockers on Survival in Patients With Cirrhosis and Refractory Ascites
Thomas Serste et al.
HEPATOLOGY (2010)
The β-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor κB signaling
Xinhua Liao et al.
ONCOLOGY REPORTS (2010)
Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival
Desmond G. Powe et al.
ONCOTARGET (2010)
Randomized Controlled Trial of Carvedilol Versus Variceal Band Ligation for the Prevention of the First Variceal Bleed
Dhiraj Tripathi et al.
HEPATOLOGY (2009)
Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis
Cristina Ripoll et al.
JOURNAL OF HEPATOLOGY (2009)
The systemic inflammatory response syndrome in cirrhotic patients: Relationship with their in-hospital outcome
Massimo Cazzaniga et al.
JOURNAL OF HEPATOLOGY (2009)
Effect of chronic β-blockade on QT interval in patients with liver cirrhosis
Andrea Zarabruni et al.
JOURNAL OF HEPATOLOGY (2008)
QT interval correction in patients with cirrhosis
Andrea Zambruni et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2007)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
G D'Amico et al.
JOURNAL OF HEPATOLOGY (2006)
Acute non-selective β-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis
JH Henriksen et al.
JOURNAL OF HEPATOLOGY (2004)
Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension
D Tripathi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites
M Perez-Paramo et al.
HEPATOLOGY (2000)
Share Paper
